BioSpace News Archive

FDA

Guardant Health receives FDA approval for Guardant360® CDx as companion diagnostic for Menarini Group’s ORSERDU™ for treatment of patients with ESR1 mutations in ER+, HER2- advanced or metastatic breast cancer

Guardant Health receives FDA approval for Guardant360 ® CDx as companion diagnostic for Menarini Group’s ORSERDU™ for treatment of patients with ESR1 mutations in ER+, HER2- advanced or metastatic breast cancer.

January 30, 2023
·
7 min read
Business

Invitae Appoints William H. Osborne to its Board of Directors

Invitae (NYSE: NVTA), a leading medical genetics company, has announced that aerospace, transportation and industrial supplies veteran William H. Osborne has been appointed to its board of directors and will also serve on its audit committee, effective January 26, 2023.

January 30, 2023
·
5 min read
Business

Aprea Therapeutics Appoints John Hamill as Chief Financial Officer

Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics targeting DNA damage response (DDR) pathways, today announced the appointment of John Hamill as Chief Financial Officer.

January 30, 2023
·
4 min read
Business

MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced that its Board of Directors has appointed Joseph H. Capper as the Company’s Chief Executive Officer and a director of the Company, effective immediately.

January 30, 2023
·
8 min read
Business

Immutep Quarterly Activities Report - Jan 30, 2023

Immutep Limited, a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune diseases, provides an update on the ongoing development of its product candidates, efti and IMP761, for the quarter ended 31 December 2022.

January 30, 2023
·
10 min read
Business

Vaccitech Appoints Industry Veteran, Nadège Pelletier, Ph.D., as Chief Scientific Officer

Vaccitech plc today announced the appointment of Nadège Pelletier, Ph.D., as Chief Scientific Officer (CSO).

January 30, 2023
·
4 min read
Biotech Beach

Kintara Therapeutics to Present at the 2023 BIO CEO & Investor Conference

Kintara Therapeutics, Inc. today announced that Robert E. Hoffman , President and CEO of Kintara, will be presenting at the BIO CEO & Investor Conference on Monday, February 6, 2023.

January 30, 2023
·
4 min read
BioMidwest

METAFORA Launches METAflow, its Digital Cytometry Analysis Platform

METAFORA biosystems, today announces the launch of METAflow, its digital flow cytometry platform, into the RUO market.

January 30, 2023
·
3 min read
Business

Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2022 Financial Results on March 1, 2023

Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its fourth-quarter and full-year 2022 financial results on Wednesday, March 1, 2023, prior to the open of U.S. financial markets.

January 30, 2023
·
1 min read
Biotech Beach

Masimo Announces the Limited Market Release of Visual Clinical Activity Monitoring (VCAM™)

Masimo (NASDAQ: MASI) today announced the limited market release of Visual Clinical Activity Monitoring (VCAM™), a video analysis system that uses artificial intelligence to help facilitate compliance with hospital hand hygiene protocols.

January 30, 2023
·
10 min read